Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,366Revenue $M2,747Net Margin (%)7.5Altman Z-Score1.1
Enterprise Value $M12,455EPS $0.7Operating Margin %18.1Piotroski F-Score7
P/E(ttm)46.6Beneish M-Score-2.8Pre-tax Margin (%)10.0Higher ROA y-yY
Price/Book4.710-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow14.1y-y EBITDA Growth Rate %2.2ROA % (ttm)2.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)9.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M279ROIC % (ttm)7.5Gross Margin Increase y-yY

Gurus Latest Trades with HOLX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HOLXKen Fisher 2016-03-31 Add$32.42 - $38.69
($34.9)
$ 33.92-3%Add 0.04%47,620
HOLXJoel Greenblatt 2015-12-31 Reduce-0.07%$36.57 - $41.22
($38.92)
$ 33.92-13%Reduce -31.40%384,989
HOLXPrem Watsa 2015-12-31 Sold Out -0.07%$36.57 - $41.22
($38.92)
$ 33.92-13%Sold Out0
HOLXKahn Brothers 2015-12-31 Add0.06%$36.57 - $41.22
($38.92)
$ 33.92-13%Add 0.61%1,350,251
HOLXVanguard Health Care Fund 2015-12-31 Reduce-0.03%$36.57 - $41.22
($38.92)
$ 33.92-13%Reduce -5.80%5,802,700
HOLXKen Fisher 2015-12-31 Reduce$36.57 - $41.22
($38.91)
$ 33.92-13%Reduce -0.07%47,600
HOLXCarl Icahn 2015-09-30 Reduce-0.73%$37.22 - $42.92
($39.66)
$ 33.92-14%Reduce -17.57%28,154,879
HOLXJoel Greenblatt 2015-09-30 Buy 0.21%$37.22 - $42.92
($39.66)
$ 33.92-14%New holding561,229
HOLXKahn Brothers 2015-09-30 Reduce-0.11%$37.22 - $42.92
($39.66)
$ 33.92-14%Reduce -1.31%1,342,012
HOLXVanguard Health Care Fund 2015-09-30 Reduce-0.09%$37.22 - $42.92
($39.66)
$ 33.92-14%Reduce -16.53%6,159,700
HOLXKen Fisher 2015-09-30 Reduce-0.01%$37.22 - $42.92
($39.66)
$ 33.92-14%Reduce -62.87%47,632
HOLXKahn Brothers 2015-06-30 Reduce-0.1%$32.47 - $38.26
($34.97)
$ 33.92-3%Reduce -1.31%1,359,812
HOLXKahn Brothers 2015-03-31 Reduce-0.06%$25.745 - $33.26
($30.69)
$ 33.9211%Reduce -3.00%1,377,802
HOLXKahn Brothers 2014-12-31 Reduce-0.48%$23.15 - $27.05
($25.82)
$ 33.9231%Reduce -7.83%1,420,442
HOLXJoel Greenblatt 2014-12-31 Sold Out $23.15 - $27.05
($25.85)
$ 33.9231%Sold Out0
HOLXJoel Greenblatt 2014-09-30 Reduce-0.06%$24.14 - $26.28
($25.24)
$ 33.9234%Reduce -92.17%16,119
HOLXJoel Greenblatt 2014-06-30 Add0.03%$20.27 - $25.6
($23.34)
$ 33.9245%Add 104.68%205,907
HOLXFirst Eagle Investment 2014-06-30 Sold Out -0.001%$20.27 - $25.6
($23.31)
$ 33.9246%Sold Out0
HOLXKahn Brothers 2014-03-31 Add0.64%$20.11 - $22.58
($21.59)
$ 33.9257%Add 15.37%1,556,979
HOLXJoel Greenblatt 2014-03-31 Reduce-0.03%$20.11 - $22.58
($21.6)
$ 33.9257%Reduce -35.86%100,601
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HOLX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HOLX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LAVANCE DAVID R JRDirector 2016-02-24Sell11,621$34.5-2.64view
Levy Lawrence MDirector 2015-11-10Sell20,000$40.7-17.47view
Levy Lawrence MDirector 2015-09-21Sell5,000$42.02-20.06view
WILSON WAYNEDirector 2015-09-08Sell100,000$39-13.87view
WILSON WAYNEDirector 2015-08-28Sell11,146$39.7-15.39view
WILSON WAYNEDirector 2015-08-26Sell25,080$38.61-13view
WILSON WAYNEDirector 2015-08-14Sell13,257$42.2-20.4view
LAVANCE DAVID R JRDirector 2015-08-05Sell97,410$41.99-20view
WILSON WAYNEDirector 2015-08-05Sell16,071$42.36-20.7view
ICAHN CARL C 2015-08-04Sell6,000,000$40.47-17view

Quarterly/Annual Reports about HOLX:

News about HOLX:

Articles On GuruFocus.com
Carl Icahn Continues to Reduce Position in Hologic Apr 07 2016 
Investment Ideas Trading With Very Low P/S Ratio Jan 13 2016 
Carl Icahn Makes Big Transactions in 3rd Quarter Jan 03 2016 
Kahn Brothers' Largest Sales During 3rd Quarter Dec 22 2015 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 
Prem Watsa's Best Performing Holdings Oct 11 2015 
Carl Icahn Provides Update on Freeport-McMoRan Oct 07 2015 
Weekly 52-Week Highs Highlight: STI, GS, HOLX, MHK Jun 09 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 

More From Other Websites
Hologic, Inc. breached its 50 day moving average in a Bearish Manner : HOLX-US : April 29, 2016 Apr 29 2016
Hologic (HOLX) Stock Tumbles Despite Q2 Earnings, Revenue Beat Apr 28 2016
Icahn on Hologic Apr 28 2016
Hologic (HOLX) Q2 Earnings, Revenues Top; FY16 View Up Apr 28 2016
Hologic downgraded by Needham Apr 28 2016
Edited Transcript of HOLX earnings conference call or presentation 27-Apr-16 8:30pm GMT Apr 28 2016
Hologic tops Street 2Q forecasts Apr 27 2016
Hologic tops Street 2Q forecasts Apr 27 2016
Study Results Published in JAMA Conclude that 3D MAMMOGRAPHY™ Exams Outperform Conventional... Apr 27 2016
4:09 pm Hologic beats by $0.01, reports revs in-line; guides Q3 EPS in-line, revs below consensus;... Apr 27 2016
HOLOGIC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 27 2016
Hologic Announces Financial Results for Second Quarter of Fiscal 2016 Apr 27 2016
Koninklijke Philips Reported Mixed Quarterly Results for 1Q16 Apr 27 2016
Q2 2016 Hologic Inc Earnings Release - After Market Close Apr 27 2016
Study Results Published in JAMA Conclude that 3D MAMMOGRAPHY™ Exams Outperform Conventional... Apr 26 2016
Med-Instrument Stocks to Post Earnings: EW, HOLX, TMO, VAR Apr 25 2016
Can Hologic (HOLX) Pull a Surprise in Q2 Earnings? Apr 22 2016
Hologic Announces FDA Clearance and Commercial Availability of the Affirm™ Prone Biopsy System,... Apr 21 2016
Hologic Announces FDA Clearance and Commercial Availability of the Affirm™ Prone Biopsy System,... Apr 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)